AKR1B10 and breast carcinoma: Given its ability to differentiate high and low Stage I disease, we think that AKR1B10 may be a protein whose expression in breast cancer tissues can further categorize this intermediate risk group of breast cancer patients and aid the clinician in the decision to administer chemotherapy.